PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
756.00
+21.00 (2.86%)
At close: Mar 6, 2026
-72.15%
Market Cap 15.20B
Revenue (ttm) 3.36B
Net Income (ttm) -7.15B
Shares Out 21.17M
EPS (ttm) -328.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 92,751
Average Volume 544,140
Open 733.00
Previous Close 735.00
Day's Range 712.00 - 759.00
52-Week Range 600.00 - 3,375.00
Beta 0.02
RSI 32.77
Earnings Date Mar 20, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 46
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2024, PeopleBio's revenue was 3.73 billion, a decrease of -16.20% compared to the previous year's 4.45 billion. Losses were -10.91 billion, -31.94% less than in 2023.

Financial Statements

News

There is no news available yet.